The efficacy of intracranial PLG-based vaccines is dependent on direct implantation into brain tissue
The efficacy of intracranial PLG-based vaccines is dependent on direct implantation into brain tissue
复制标题
DOI:
10.1016/j.jconrel.2011.06.021
复制
发表时间:
2011-09-25
影响因子:
10.8
通讯作者:
Emerich, Dwaine F.
中科院分区:
文献类型:
--
作者:
Ali, Omar A.;Doherty, Edward;Emerich, Dwaine F.
We previously engineered a macroporous, polymer-based vaccine that initially produces GM-CSF gradients to recruit local dendritic cells and subsequently presents CpG oligonucleotides, and tumor lysate to cell infiltrates to induce immune cell activation and immunity against tumor cells in peripheral tumor models. Here, we demonstrate that this system eradicates established intracranial glioma following implantation into brain tissue, whereas implantation in resection cavities obviates vaccine efficacy. Rats bearing seven-day old, intracranial glioma tumors were treated with PLC vaccines implanted into the tumor bed, resulting in retention of contralateral forelimb function (day 17) that is compromised by tumor formation in control animals, and 90% long-term survival (>100 days). Similar benefits were observed in animals receiving tumor resection plus vaccine implants into the adjacent parenchyma, but direct implantation of PLC vaccines into the resection cavity conferred no benefit. This dissociation of efficacy was likely related to GM-CSF distribution, as implantation of PLC vaccines within brain tissue produced significant GM-CSF gradients for prolonged periods, which was not detected after implantation in resection cavities. These studies demonstrate that PLC vaccine efficacy is correlated to GM-CSF gradient formation, which requires direct implantation into brain tissue, and justify further exploration of this approach for glioma treatment. (C) 2011 Elsevier B.V. All rights reserved.